Key result
Unexplained dyspnoea in patients with Type 2 diabetes was associated with a higher prevalence of mPAP/COslope > 3 during exercise compared to asymptomatic patients (61% vs 30%, P=0.009).
Why the study?
The study was conducted to compare cardiac and pulmonary vascular function during exercise between dyspnoeic and non-dyspnoeic patients with Type 2 diabetes mellitus.
Does unexplained exertional dyspnoea correlate with impaired cardiac and pulmonary vascular function during exercise in patients with Type 2 diabetes?
Observational (n=97)
Does unexplained exertional dyspnoea correlate with impaired cardiac and pulmonary vascular function during exercise in patients with Type 2 diabetes?
Absolute Event Rate: 61% vs 30%
p-value: p=0.009
Unexplained exertional dyspnoea in patients with Type 2 diabetes is associated with exercise-induced pulmonary hypertension and reduced left ventricular systolic reserve.
Should not yet change dyspnoea evaluation in type 2 diabetes; leaves open whether exercise haemodynamics warrant prospective validation.
AIMS: To compare the cardiac function and pulmonary vascular function during exercise between dyspnoeic and non-dyspnoeic patients with Type 2 diabetes mellitus (T2DM). METHODS AND RESULTS: Forty-seven T2DM patients with unexplained dyspnoea and 50 asymptomatic T2DM patients underwent exercise echocardiography combined with ergospirometry. Left ventricular (LV) function [stroke volume, cardiac output (CO), LV ejection fraction, systolic annular velocity (s')], estimated LV filling pressures (E/e'), mean pulmonary arterial pressures (mPAPs) and mPAP/COslope were assessed at rest, low- and high-intensity exercise with colloid contrast. Groups had similar patient characteristics, glycemic control, stroke volume, CO, LV ejection fraction, and E/e' (P > 0.05). The dyspnoeic group had significantly lower systolic LV reserve at peak exercise (s') (P = 0.021) with a significant interaction effect (P < 0.001). The dyspnoeic group also had significantly higher mPAP and mPAP/CO at rest and exercise (P < 0.001) with significant interaction for mPAP (P < 0.009) and insignificant for mPAP/CO (P = 0.385). There was no significant difference in mPAP/COslope between groups (P = 0.706). However, about 61% of dyspnoeic vs. 30% of non-dyspnoeic group had mPAP/COslope > 3 (P = 0.009). The mPAP/COslope negatively predicted V̇O2peak in dyspneic group (β = -1.86, 95% CI: -2.75, -0.98; multivariate model R2:0.54). CONCLUSION: Pulmonary hypertension and less LV systolic reserve detected by exercise echocardiography with colloid contrast underlie unexplained exertional dyspnoea and reduced exercise capacity in T2DM.
No takes yet. Share an insight, caveat, or question.
Gojevic et al. (2022) conducted an observational in Type 2 diabetes mellitus (n=97). Unexplained dyspnoea vs. Asymptomatic (non-dyspnoeic) was evaluated on mPAP/COslope > 3 (p=0.009). Unexplained dyspnoea in patients with Type 2 diabetes was associated with a higher prevalence of mPAP/COslope > 3 during exercise compared to asymptomatic patients (61% vs 30%, P=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: